Open AccessmTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation
Author(s) -
Naoki Osada,
Jiro Kikuchi,
Daisuke Koyama,
Yuko Kuroda,
Hiroshi Yasui,
Joel D. Leverson,
Yusuke Furukawa
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.278506
Subject(s) - venetoclax , multiple myeloma , downregulation and upregulation , pi3k/akt/mtor pathway , cancer research , discovery and development of mtor inhibitors , medicine , apoptosis , immunology , biology , leukemia , genetics , gene , chronic lymphocytic leukemia
Not available.